Stocks or ETFs side by side: scores, returns, risk, valuation and what they hold.
| Measure | ABBVAbbVie Inc. | NVSNovartis AG |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Country | United States | Switzerland |
| Market cap | $519B | $308B |
| Price | $293.89 | $163.26 |
| Last day | +0.20% | −0.26% |
, a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide.
ABBV analysis and Q-Scores →Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVS analysis and Q-Scores →Data as of 2026-10-13. Not investment advice.